Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Central Serous Chorioretinopathy
NCT02215330Phase 3Unknown
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in Central Serous Chorioretinopathy (CSCR). Status: unknown.
02
Drugs
eplerenone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT02215330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215330.